Approved Vaccines

Last Updated 4 March 2023.

50 Vaccines Approved by at Least One Country

The vaccines listed below are those that have been approved, authorized, licensed, granted emergency use authorization, or made available for use outside of clinical trials via any pathway by a regulatory agency, a national authority, or another entity.

• Anhui Zhifei Longcom
  Zifivax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  21 trials in 5 countries

  Protein Subunit

• Bagheiat-allah University of Medical Sciences
  Noora vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  3 trials in 1 country

  Protein Subunit

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 14 countries

  16 trials in 2 countries

  Inactivated

• Bharat Biotech
  iNCOVACC

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  4 trials in 1 country

  Non Replicating Viral Vector

• Biological E Limited
  Corbevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  7 trials in 1 country

  Protein Subunit

• CanSino
  Convidecia

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 10 countries

  14 trials in 6 countries

  Non Replicating Viral Vector

• CanSino
  Convidecia Air

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  5 trials in 4 countries

  Non Replicating Viral Vector

• Center for Genetic Engineering and Biotechnology (CIGB)
  Abdala

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 6 countries

  5 trials in 1 country

  Protein Subunit

• Chumakov Center
  KoviVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 3 countries

  3 trials in 1 country

  Inactivated

• Gamaleya
  Gam-COVID-Vac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 0 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik Light

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 26 countries

  7 trials in 3 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 74 countries

  25 trials in 8 countries

  Non Replicating Viral Vector

• Gennova Biopharmaceuticals Limited
  GEMCOVAC-19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  RNA

• Health Institutes of Turkey
  Turkovac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  8 trials in 1 country

  Inactivated

• Instituto Finlay de Vacunas Cuba
  Soberana 02

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  7 trials in 2 countries

  Protein Subunit

• Instituto Finlay de Vacunas Cuba
  Soberana Plus

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  5 trials in 1 country

  Protein Subunit

• Janssen (Johnson & Johnson)
  Jcovden

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 113 countries

  26 trials in 25 countries

  Non Replicating Viral Vector

• Livzon Mabpharm Inc
  V-01

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 3 countries

  Protein Subunit

• Medicago
  Covifenz

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  6 trials in 6 countries

  VLP

• Medigen
  MVC-COV1901

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  15 trials in 4 countries

  Protein Subunit

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  70 trials in 24 countries

  RNA

• Moderna
  Spikevax Bivalent Original/Omicron BA.1

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 38 countries

  5 trials in 4 countries

  RNA

• Moderna
  Spikevax Bivalent Original/Omicron BA.4/BA.5

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 33 countries

  2 trials in 1 country

  RNA

• National Vaccine and Serum Institute
  Recombinant SARS-CoV-2 Vaccine (CHO Cell)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  3 trials in 2 countries

  Protein Subunit

• Novavax
  Nuvaxovid

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 40 countries

  22 trials in 14 countries

  Protein Subunit

• Organization of Defensive Innovation and Research
  FAKHRAVAC (MIVAC)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  3 trials in 1 country

  Inactivated

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Non Replicating Viral Vector

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  100 trials in 31 countries

  RNA

• Pfizer/BioNTech
  Comirnaty Bivalent Original/Omicron BA.1

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 35 countries

  3 trials in 5 countries

  RNA

• Pfizer/BioNTech
  Comirnaty Bivalent Original/Omicron BA.4/BA.5

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 33 countries

  4 trials in 1 country

  RNA

• PT Bio Farma
  IndoVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  4 trials in 1 country

  Protein Subunit

• Razi Vaccine and Serum Research Institute
  Razi Cov Pars

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  5 trials in 1 country

  Protein Subunit

• Research Institute for Biological Safety Problems (RIBSP)
  QazVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  3 trials in 1 country

  Inactivated

• Sanofi/GSK
  VidPrevtyn Beta

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 30 countries

  3 trials in 2 countries

  Protein Subunit

• Serum Institute of India
  Covishield (Oxford/ AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 49 countries

  6 trials in 1 country

  Non Replicating Viral Vector

• Serum Institute of India
  COVOVAX (Novavax formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 6 countries

  7 trials in 3 countries

  Protein Subunit

• Shenzhen Kangtai Biological Products Co
  KCONVAC

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  7 trials in 1 country

  Inactivated

• Shifa Pharmed Industrial Co
  COVIran Barekat

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  6 trials in 1 country

  Inactivated

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 93 countries

  39 trials in 18 countries

  Inactivated

• Sinopharm (Wuhan)
  Inactivated (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 2 countries

  9 trials in 7 countries

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  42 trials in 10 countries

  Inactivated

• SK Bioscience Co Ltd
  SKYCovione

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 6 countries

  Protein Subunit

• Takeda
  TAK-019 (Novavax formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  3 trials in 1 country

  Protein Subunit

• Takeda
  TAK-919 (Moderna formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  RNA

• Valneva
  VLA2001

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 33 countries

  9 trials in 4 countries

  Inactivated

• Vaxine/CinnaGen Co.
  SpikoGen

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  8 trials in 2 countries

  Protein Subunit

• Vector State Research Center of Virology and Biotechnology
  Aurora-CoV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  2 trials in 1 country

  Protein Subunit

• Vector State Research Center of Virology and Biotechnology
  EpiVacCorona

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  4 trials in 1 country

  Protein Subunit

• Walvax
  AWcorna

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  4 trials in 3 countries

  RNA

• Zydus Cadila
  ZyCoV-D

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  6 trials in 1 country

  DNA